JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopardo, H. A.
Right arrow Articles by Elliott, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopardo, H. A.
Right arrow Articles by Elliott, J.
Journal of Clinical Microbiology, October 2003, p. 4688-4694, Vol. 41, No. 10
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.10.4688-4694.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Six-Month Multicenter Study on Invasive Infections Due to Group B Streptococci in Argentina

Horacio A. Lopardo,1* Patricia Vidal,1 Paola Jeric,2 Daniela Centron,2 Hugo Paganini,3 Richard R. Facklam,4 The Argentinian Streptococcus Study Group,{dagger} and John Elliott4

Servicio de Microbiología,1 Servicio de Epidemiología, Infectología y Medicina Preventiva, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan",3 Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina,2 Division of Bacterial and Mycotic Diseases, Respiratory Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia4

Received 9 April 2003/ Returned for modification 9 June 2003/ Accepted 30 July 2003

There is little information about invasive infections by group B streptococci (GBS) and their antimicrobial susceptibilities in Latin America. We performed a prospective multicenter study to determine the serotype distribution and the antimicrobial susceptibility of GBS in Argentina. We identified 58 cases, but only 44 had sufficient data to be evaluated. Eight early-, four late-, and one fatal late, late-onset neonatal infections due to GBS were found. A total of 31 patients were adults with bacteremia, skin and soft tissue infections, osteomyelitis, arthritis, meningitis, abdominal infections, and renal abscess. Serotype III was prevalent in late-onset neonatal disease, and several serotypes (Ia/c, III, Ia, and II) were involved in early-onset neonatal infections. Serotypes II, Ia/c, III, and IV were commonly found in adults, with serotype II prevalent in younger adults (18 to 69 years old) and serotype Ia/c prevalent in elderly adults (>70 years old). The mortality rate attributable to GBS infections was 10.8%. All GBS were susceptible to penicillin and ceftriaxone. Resistance to clindamycin (1.7%), erythromycin (5.2%), azithromycin (5.2%), minocycline (69%), and tetracycline (72.4%), to high levels of kanamycin and amikacin (1.7%), and to intermediately high levels of gentamicin (1.7%) was observed. The bifunctional enzyme AAC6'-APH2" was detected in the isolate resistant to aminoglycosides, and other genetic determinants were identified in other resistant isolates: tetM and tetO in tetracycline-resistant streptococci and mefA and ermTR for efflux-mediated and inducible macrolide-lincosamide-streptogramin B-resistant streptococci, respectively. For clinical purposes and rapid and easy detection of high-level aminoglycoside-resistant GBS, a screening method that used 1,000-µg kanamycin disks is proposed.


* Corresponding author. Mailing address: Microbiología, Hospital de Pediatría, "Prof. Dr. Juan P. Garrahan," Combate de los Pozos 1881, 1245 Buenos Aires, Argentina. Phone: 54-11-4308-4300, ext. 1224. Fax: 54-11-4308-5325. E-mail: hlopardo{at}garrahan.gov.ar.

{dagger} The members of the Argentinian Streptococcus Study Group are listed in Acknowledgments.


Journal of Clinical Microbiology, October 2003, p. 4688-4694, Vol. 41, No. 10
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.10.4688-4694.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.